New Partnership Boosts Crohn's Disease and Ulcerative Colitis Research

Introduction

Azenta, Inc. has entered into a collaboration with the Crohn's & Colitis Foundation to provide sample management services for advanced research on Crohn's disease and ulcerative colitis through the CAPTURE IBD and IBD SIRQC studies. This partnership is set to drive critical advancements in understanding and treating these chronic inflammatory bowel diseases.

Significance of the Collaboration

The collaboration highlights the importance of robust sample management in pushing forward clinical research in the field of gastroenterology. With Azenta handling sample processing, analysis, logistics, and storage, researchers can focus more on innovative therapies and precision medicine strategies to combat Crohn's and colitis.

Utilizing Azenta’s expertise in sample management ensures high-quality data and biosamples for the Crohn's & Colitis Foundation’s IBD Plexus® platform, enabling researchers to advance next-generation discoveries and developing novel treatments.

Overview of the CAPTURE IBD Study

CAPTURE IBD (Cohort for Pediatric Translational and Clinical Research in Inflammatory Bowel Disease) is dedicated to pediatric research. This multi-center, longitudinal study aims to enhance precision medicine for pediatric IBD, enrolling thousands of children at multiple sites across the United States.

The study’s goal is to provide in-depth, long-term data to understand pediatric IBD better and tailor treatment options to improve patient outcomes. Insights from CAPTURE IBD can lead to more effective, personalized therapies for young patients suffering from these conditions.

Details on the IBD SIRQC Study

IBD SIRQC (Surgical Innovation, Research, and Quality Collaborative) is the first surgical-focused research initiative by the Foundation. This longitudinal study will track surgical outcomes, including complications and disease recurrence, post-procedure in Crohn’s and colitis patients.

The study will enroll 5,000 participants at various locations in the United States, aiming to generate valuable data that will aid in improving surgical techniques and postoperative care, thereby enhancing the quality of life for patients undergoing surgical interventions.

Impact on Research and Patient Care

By integrating data from both CAPTURE IBD and IBD SIRQC into the IBD Plexus® platform, the Crohn's & Colitis Foundation and Azenta aim to create a comprehensive data resource that facilitates high-impact research. This integration helps in understanding the complexities of IBD, ultimately driving forward precision medicine and innovative treatment strategies.

Increased access to well-organized, high-quality samples and data accelerates the research process, making it possible to achieve breakthroughs at a faster pace. This can significantly impact patient care, offering better disease management options and improving life quality for those affected by IBD.

The Role of Azenta in the Partnership

Azenta’s role extends beyond mere sample storage. Their services include sample processing, detailed analysis, logistics coordination, and storage solutions. Their involvement ensures that the samples and data remain consistent, reliable, and ready for immediate use by researchers.

Having proven their capabilities in previous collaborations, Azenta’s reliable cold-chain sample management and multiomics services effectively support the Foundation's critical research endeavors, reinforcing the importance of quality control in clinical research.

Conclusion

The partnership between Azenta and the Crohn's & Colitis Foundation marks a significant step forward in the fight against inflammatory bowel diseases. By leveraging Azenta's sample management expertise, the Foundation can enhance the quality and speed of research, bringing hope for better treatment options and eventually a cure for Crohn's disease and ulcerative colitis.

About the Crohn's & Colitis Foundation

The Crohn's & Colitis Foundation is a leading nonprofit organization focused on advancing research and patient support for inflammatory bowel disease (IBD). Their mission is to find cures for Crohn's disease and ulcerative colitis while improving the lives of those affected by these conditions. They provide extensive educational and support resources for patients, families, healthcare professionals, and the public.

About Azenta, Inc.

Azenta, Inc. is a global leader in life sciences solutions, providing advanced sample management services and multiomics solutions. They serve various sectors including drug development, clinical research, and advanced cell therapies. Azenta’s commitment to quality and innovation helps accelerate impactful breakthroughs in the healthcare industry.